Cerner Co. (NASDAQ:CERN) Director William D. Zollars sold 4,100 shares of Cerner stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $62.16, for a total value of $254,856.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Shares of Cerner Co. (NASDAQ CERN) opened at $62.49 on Tuesday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.99 and a current ratio of 3.01. The firm has a market capitalization of $20,770.00, a P/E ratio of 24.32, a price-to-earnings-growth ratio of 1.84 and a beta of 0.90. Cerner Co. has a 1-year low of $51.26 and a 1-year high of $73.86.
Cerner (NASDAQ:CERN) last released its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.61 earnings per share. equities research analysts predict that Cerner Co. will post 2.42 EPS for the current fiscal year.
A number of equities research analysts recently weighed in on CERN shares. Royal Bank of Canada reissued a “buy” rating and set a $74.00 target price on shares of Cerner in a research report on Wednesday, November 22nd. Piper Jaffray Companies reissued a “buy” rating and set a $70.00 target price on shares of Cerner in a research report on Wednesday, November 22nd. SunTrust Banks reissued a “buy” rating and set a $79.00 target price on shares of Cerner in a research report on Thursday, October 19th. Zacks Investment Research raised Cerner from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research report on Tuesday, October 17th. Finally, Jefferies Group reissued a “buy” rating on shares of Cerner in a research report on Sunday, October 29th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have issued a buy rating to the company’s stock. Cerner currently has an average rating of “Hold” and a consensus price target of $67.05.
Several institutional investors and hedge funds have recently made changes to their positions in CERN. GSA Capital Partners LLP acquired a new position in shares of Cerner in the 2nd quarter worth approximately $293,000. Dimensional Fund Advisors LP boosted its holdings in shares of Cerner by 7.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 697,200 shares of the company’s stock worth $46,342,000 after acquiring an additional 47,812 shares in the last quarter. Cubist Systematic Strategies LLC boosted its holdings in shares of Cerner by 741.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 9,825 shares of the company’s stock worth $653,000 after acquiring an additional 8,658 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Cerner by 1.9% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 16,515 shares of the company’s stock worth $1,098,000 after acquiring an additional 302 shares in the last quarter. Finally, Nomura Holdings Inc. boosted its holdings in shares of Cerner by 97.5% in the 2nd quarter. Nomura Holdings Inc. now owns 26,940 shares of the company’s stock worth $1,792,000 after acquiring an additional 13,301 shares in the last quarter. 81.58% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Cerner Co. (CERN) Director William D. Zollars Sells 4,100 Shares” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/13/cerner-co-cern-director-william-d-zollars-sells-4100-shares.html.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.